Interní Med. 2008; 10(6): 277-280

Acid-related diseases - main indication for proton pump inhibitors

doc. MUDr. Václav Jirásek CSc
I. interní klinika 1. LF UK a VFN Praha

Proton pump inhibitors (PPI) are effective for treatment of all acid-related disorders, i. e. gastroesophageal reflux disease, peptic ulcer disease and eradication of Helicobacter pylori, nonsteroidal anti-inflammatory drugs associated peptic ulcers, ulcers of endocrine origin, stress ulcers as well as peptic ulcer bleeding. Proton pump inhibitors are relative safe drugs with minimum interactions. All in Czech republic available agents – omeprazol, pantoprazol, lansoprazol – are simillary effective.

Keywords: Key words: proton pump inhibitors (PPIs), acid-related diseases, gastroesophageal reflux disease, peptic ulcer disease, NSAID gastropathy, omeprazol, pantoprazol, lansoprazol.

Published: July 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jirásek V. Acid-related diseases - main indication for proton pump inhibitors. Interní Med. 2008;10(6):277-280.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bureš J. et al. Infekce Helicobacter pylori. Čes. a slov. Gastroent. a Hepatol. 2004; 58 (4): 151-155.
    2. Dítě P. Vředová nemoc žaludku a dvanáctníku, současné léčebné trendy. Interní Med. 2006; 8 (5): 231-234.
    3. Dítě P. a kol. Akutní stavy v gastroenterologii. Praha: Galen 2005: 314 s.
    4. Fixa B, Komárková O, Nožička Z. Možnosti a význam eradikace Helicobacter pylori u osob s onemocněním žaludku. Vnitř. Lék. 1995; 41 (3): 176-178.
    5. Forejtová Š. Současný pohled na terapii nesteroidními antirevmatiky. Interní Med. 2008; 10 (3): 121-125.
    6. Galmiche JP, Des Vrannes SD, Ducrotté P. et al. Tenatoprazole, a novel proton pump inhibitor with prolonged plasma half-life Aliment. Pharmacol. Ther. 2004; 19 (6): 665-662. Go to original source... Go to PubMed...
    7. Jirásek V, Vojtíšková J, Dítě P, et al. Peptický vřed. Doporučený diagnostický a léčebný postup pro praktické lékaře. Čes. a slov. Gastroent. a Hepatol. 2004; 58 (5): 194-196.
    8. Jirásek V. Vývoj inhibitorů protonové pumpy - etapy v léčbě onemocnění s acidopeptickou patogenezou. Interní Med. 2003; 10: 487-490.
    9. Kala Z. a kol. Refluxní choroba jícnu. Praha, Grada Publishing, 2003.
    10. Kolektiv autorů. Aktualizované doporučené postupy pro praktické lékaře. Peptický vřed. Refluxní choroba jícnu. Prevence a léčba gastropatie z nesteroidních antirevmatik. Dyspepsie horního typu. Společnost všeobecného lékařství, 2003: s. 28.
    11. Laine L. Approaches to nesteroidal anti-inflammatory drug use in high-risk patient. Gastroenterology 2001; 120: 594-606. Go to original source... Go to PubMed...
    12. Lind, T, Rydberg L, Kyleback A: et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol. Ther 2000; 4 (7): 861-867. Go to original source... Go to PubMed...
    13. Lukáš K. Historie endoskopie - 200 let dokumentované endoskopie (1806-2006). Čes. a Slov. Gastroent. a Hepatol. 2005; 59 (6): 299-308.
    14. Olbe L. (editor). Proton pump inhibitors. Basel, Boston, Berlin: Birkäuser Verlag, 1999: 251 s. Go to original source...
    15. Ramakrishnen K, Salina R. Peptická vředová choroba. Medicína po promoci 2008; 9 (1): 14-22.
    16. Refluxní choroba jícnu. Standardy ČSG. K. Lukáš (koordinátor): Čes. a slov. Gastroent. a Hepatol. 2003; 57: 23-29.
    17. Robinson M. Fitzgerald S. Hegedus R, et al. Onset of symptom relief with rabeprazole: a communita-based, open label assemment of patients with erosive oesophitis. Aliment. Pharmacol Ther. 2002; 16 (3): 445-454. Go to original source... Go to PubMed...
    18. Scarpignato C, Pelosini I, Di Mario F. Acid suppression therapy: where do we go from here?. Dig Dis 2006; 24, (1-2): 11-46. Go to original source... Go to PubMed...
    19. Warren R, Marshall B. Unidentified curved bacilli on gastric epithelium in active gastritis. Lancet (letter): 1983; 1: 1273-1275. Go to original source...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.